RAHWAY, N.J. (January 15, 2021) — Grignard Pure today announced that its Grignard Pure™ product has received approval from the U.S. Environmental Protection Agency (EPA) as the first and only EPA-approved antimicrobial air treatment solution designed to significantly reduce the viral load of the SARS-CoV-2 virus in the air, where transmission is most likely. The EPA undertook a thorough review of the product’s health, safety and efficacy performance and determined that Grignard Pure is expected to kill more than 98% of the virus that causes COVID-19.
“I’ve worked closely with the Grignard Pure team since April 2020 to assure the effectiveness of the solution. Adding Grignard Pure to a safety protocol including personal hygiene, masks and social distancing, is a critical step toward helping to restore the social, cultural and business norms we enjoyed pre-pandemic.”
The approval comes in the form of a Section 18 Public Health Emergency Exemption. The Emergency Exemptions are initially approved for use in two states: Georgia and Tennessee. The EPA seeks to oversee a controlled rollout to ensure an effective management of supply for operations deemed essential by each state. It is expected that additional states will submit applications for Section 18 Emergency Exemption in the coming days and weeks. Grignard Pure is in discussions with the EPA to pursue a national approval which would cover all indoor activities.
“We are deeply grateful to the diligent teams at EPA who were tireless in evaluating and validating the health, safety and efficacy of Grignard Pure as the first-of-its-kind antimicrobial air treatment solution,” said Etienne Grignard, co-founder and CEO, Grignard Pure. “Grignard Pure is a passion and a mission for us. Since the beginning of the pandemic, we have been singularly focused on making Grignard Pure a critical component in achieving the shared commitment we all have – helping people feel safer, getting industries and our economy back to full operation, and using science, engineering and technology to find solutions that move us past the ravages of COVID-19.”
“Today, we are approving the first-ever airborne antiviral product that will help fight the spread of the novel coronavirus that causes COVID-19,” said EPA Administrator Andrew Wheeler. “There is no higher priority for EPA than protecting the health and safety of Americans and I want to thank those – both within EPA and those outside – who have worked to achieve this important milestone.”
